Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 USD | -12.62% | +7.27% | -69.01% |
May. 02 | Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology | CI |
Apr. 29 | Maxim Downgrades Nuwellis to Hold | MT |
Financials (USD)
Sales 2024 * | 10.16M | Sales 2025 * | 11.78M | Capitalization | 2.74M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -16M | EV / Sales 2024 * | 0.27 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.23 x |
P/E ratio 2024 * |
-0.1
x | P/E ratio 2025 * |
-0.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on Nuwellis, Inc.
1 day | -12.62% | ||
1 week | +7.27% | ||
Current month | +16.58% | ||
1 month | -53.25% | ||
3 months | -62.50% | ||
6 months | -76.00% | ||
Current year | -69.01% |
Managers | Title | Age | Since |
---|---|---|---|
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 19-05-06 |
Robert Scott
DFI | Director of Finance/CFO | 44 | 12-12-31 |
John Erb
CHM | Chairman | 75 | 12-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Erb
CHM | Chairman | 75 | 12-08-31 |
Director/Board Member | 61 | Oct. 31 | |
Gregory Waller
BRD | Director/Board Member | 74 | 11-08-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.18 | -12.62% | 10,920,826 |
24-05-02 | 0.206 | +54.89% | 72,293,040 |
24-05-01 | 0.133 | -13.86% | 2,893,529 |
24-04-30 | 0.1544 | +7.22% | 2,220,577 |
24-04-29 | 0.144 | -14.18% | 4,853,954 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.01% | 2.74M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- NUWE Stock